Literature DB >> 18830105

Receiver operating characteristic analysis of diffusion-weighted magnetic resonance imaging in differentiating hepatic hemangioma from other hypervascular liver lesions.

Josephina A Vossen1, Manon Buijs, Eleni Liapi, John Eng, David A Bluemke, Ihab R Kamel.   

Abstract

PURPOSE: To evaluate the role of diffusion-weighted imaging in differentiating between hepatic hemangiomas, both typical and atypical, and other hypervascular liver lesions.
METHODS: Retrospective review of 182 hypervascular liver lesions in 117 patients was performed. Diffusion and contrast-enhanced magnetic resonance imaging were performed using a 1.5-T unit. Imaging protocol consisted of T2-weighted fast spin-echo images, breath-hold diffusion-weighted echo-planar images, and breath-hold unenhanced and contrast-enhanced T1-weighted 3-dimensional fat-suppressed spoiled gradient-echo images in the arterial phase (20 seconds) and portal venous phase (60 seconds). Signal intensity changes and apparent diffusion coefficient (ADC) values were evaluated for all lesions. Unpaired t test was used to compare the mean ADC values for different lesions, and statistical significance was set at P < 0.01. Receiver operating characteristic analysis was used to determine the accuracy of diffusion-weighted imaging in differentiating hemangiomas from other hypervascular liver lesions.
RESULTS: Lesions included typical and atypical hemangioma (n = 38), hepatocellular carcinoma (HCC; n = 58), focal nodular hyperplasia (FNH; n = 22), and neuroendocrine tumor metastasis (NET; n = 64) with a mean tumor size of 5.3 cm. Mean ADC value for hemangioma, HCC, FNH, and NET was 2.29 x 10(-3), 1.55 x 10(-3), 1.65 x 10(-3), and 1.43 x 10(-3) mm2/s, respectively. There was a statistically significant difference in the ADC value of hemangioma compared with that of FNH (P < 0.001), HCC (P < 0.001), and NET (P < 0.001), respectively. The area under the receiver operating characteristic curve was 0.91.
CONCLUSIONS: Diffusion-weighted magnetic resonance imaging and ADC maps can provide rapid quantifiable information to differentiate typical and atypical hemangiomas from other hypervascular liver lesions.

Entities:  

Mesh:

Year:  2008        PMID: 18830105      PMCID: PMC2760589          DOI: 10.1097/RCT.0b013e31816a6823

Source DB:  PubMed          Journal:  J Comput Assist Tomogr        ISSN: 0363-8715            Impact factor:   1.826


  51 in total

1.  The functional diffusion map: an imaging biomarker for the early prediction of cancer treatment outcome.

Authors:  Bradford A Moffat; Thomas L Chenevert; Charles R Meyer; Paul E McKeever; Daniel E Hall; Benjamin A Hoff; Timothy D Johnson; Alnawaz Rehemtulla; Brian D Ross
Journal:  Neoplasia       Date:  2006-04       Impact factor: 5.715

Review 2.  Focal hepatic lesions: diagnostic value of enhancement pattern approach with contrast-enhanced 3D gradient-echo MR imaging.

Authors:  Khaled M Elsayes; Vamsidhar R Narra; Yuming Yin; Govind Mukundan; Markus Lammle; Jeffrey J Brown
Journal:  Radiographics       Date:  2005 Sep-Oct       Impact factor: 5.333

3.  Education and imaging. Hepatobiliary and pancreatic: calcified cavernous hemangiomas in the liver.

Authors:  N Toshikuni; S Takagi; K Morii; M Fujisawa
Journal:  J Gastroenterol Hepatol       Date:  2006-10       Impact factor: 4.029

4.  Evaluation of hepatic lesions and hepatic parenchyma using diffusion-weighted echo-planar MR with three values of gradient b-factor.

Authors:  Takao Moteki; Hiroyuki Horikoshi
Journal:  J Magn Reson Imaging       Date:  2006-09       Impact factor: 4.813

5.  Mangafodipir trisodium-enhanced MRI for the detection and characterization of focal hepatic lesions: is delayed imaging useful?

Authors:  Jae-Joon Chung; Myeong-Jin Kim; Ki Whang Kim
Journal:  J Magn Reson Imaging       Date:  2006-05       Impact factor: 4.813

6.  Quantitative evaluation of diffusion-weighted magnetic resonance imaging of focal hepatic lesions.

Authors:  Xi-Jie Sun; Xian-Yue Quan; Fan-Heng Huang; Yi-Kai Xu
Journal:  World J Gastroenterol       Date:  2005-11-07       Impact factor: 5.742

7.  CT and MR imaging evaluation of hepatic adenoma.

Authors:  Giuseppe Brancatelli; Michael P Federle; Marie-Pierre Vullierme; Roberto Lagalla; Massimo Midiri; Valérie Vilgrain
Journal:  J Comput Assist Tomogr       Date:  2006 Sep-Oct       Impact factor: 1.826

8.  Comparison of CT during arterial portography and MR during arterial portography in the detection of liver metastases.

Authors:  W P Hosch; S M Schmidt; S Plaza; C Dechow; J Schmidt; S Ley; G W Kauffmann; J Hansmann
Journal:  AJR Am J Roentgenol       Date:  2006-06       Impact factor: 3.959

9.  Hepatic metastases: diffusion-weighted sensitivity-encoding versus SPIO-enhanced MR imaging.

Authors:  Katsuhiro Nasu; Yoshihumi Kuroki; Shigeru Nawano; Seiko Kuroki; Tatsuaki Tsukamoto; Seiji Yamamoto; Ken Motoori; Takuya Ueda
Journal:  Radiology       Date:  2006-02-21       Impact factor: 11.105

Review 10.  Imaging of liver metastases: MRI.

Authors:  Saravanan Namasivayam; Diego R Martin; Sanjay Saini
Journal:  Cancer Imaging       Date:  2007       Impact factor: 3.909

View more
  14 in total

Review 1.  Lesion discrimination with breath-hold hepatic diffusion-weighted imaging: a meta-analysis.

Authors:  Zhi-Guang Chen; Li Xu; Si-Wei Zhang; Yan Huang; Rui-Huan Pan
Journal:  World J Gastroenterol       Date:  2015-02-07       Impact factor: 5.742

2.  MR imaging of primary hepatic neuroendocrine neoplasm and metastatic hepatic neuroendocrine neoplasm: a comparative study.

Authors:  RuoFan Sheng; YanHong Xie; MengSu Zeng; Yuan Ji; ShengXiang Rao; CaiZhong Chen
Journal:  Radiol Med       Date:  2015-04-24       Impact factor: 3.469

Review 3.  [Diffusion-weighted magnetic resonance imaging of the abdomen].

Authors:  C Schmid-Tannwald; M F Reiser; C J Zech
Journal:  Radiologe       Date:  2011-03       Impact factor: 0.635

4.  Imaging of gastroenteropancreatic neuroendocrine tumors.

Authors:  Eik Hock Tan; Cher Heng Tan
Journal:  World J Clin Oncol       Date:  2011-01-10

5.  Diagnosis of liver metastases: value of diffusion-weighted MRI compared with gadolinium-enhanced MRI.

Authors:  Andrew D Hardie; Mohit Naik; Elizabeth M Hecht; Hersh Chandarana; Lorenzo Mannelli; James S Babb; Bachir Taouli
Journal:  Eur Radiol       Date:  2010-02-11       Impact factor: 5.315

6.  Early response of hepatic malignancies to locoregional therapy-value of diffusion-weighted magnetic resonance imaging and proton magnetic resonance spectroscopy.

Authors:  Susanne Bonekamp; Jialin Shen; Nouha Salibi; Hong C Lai; Jeff Geschwind; Ihab R Kamel
Journal:  J Comput Assist Tomogr       Date:  2011 Mar-Apr       Impact factor: 1.826

7.  Spontaneous rupture of hepatic hemangiomas: A review of the literature.

Authors:  Marcelo Af Ribeiro; Francine Papaiordanou; Juliana M Gonçalves; Eleazar Chaib
Journal:  World J Hepatol       Date:  2010-12-27

Review 8.  Prognostication and response assessment in liver and pancreatic tumors: The new imaging.

Authors:  Riccardo De Robertis; Paolo Tinazzi Martini; Emanuele Demozzi; Gino Puntel; Silvia Ortolani; Sara Cingarlini; Andrea Ruzzenente; Alfredo Guglielmi; Giampaolo Tortora; Claudio Bassi; Paolo Pederzoli; Mirko D'Onofrio
Journal:  World J Gastroenterol       Date:  2015-06-14       Impact factor: 5.742

9.  [Importance of diffusion imaging in liver metastases].

Authors:  P Riffel; S O Schoenberg; J Krammer
Journal:  Radiologe       Date:  2017-05       Impact factor: 0.635

10.  Comparison of Dynamic and Liver-Specific Gadoxetic Acid Contrast-Enhanced MRI versus Apparent Diffusion Coefficients.

Authors:  John N Morelli; Henrik J Michaely; Mathias M Meyer; Thassilo Rustemeyer; Stefan O Schoenberg; Ulrike I Attenberger
Journal:  PLoS One       Date:  2013-06-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.